Stay updated with breaking news from Aser Surgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ipsen’s Onivyde is now FDA approved as a first-line treatment for metastatic pancreatic cancer, triggering a milestone payment to Merrimack Pharmaceuticals, the drug’s original developer. Merrimack plans to dissolve operations but its shareholders will receive payouts from the Ipsen payment.
Providing a clear and unwavering roadmap of anticipated milestones will ensure that no matter the inevitable bumps or detours, your stakeholders can always see the path forward and track your progress.
The event will take place in Chicago at the Ritz Carlton from May 21-22. The startup tracks include: oncology, cardiology, women's health and preventing burnout/supporting operational efficiency. The deadline to submit applications is February 29 so apply today!
Versant Ventures-backed Firefly Bio is part of a growing group of companies developing degrader antibody conjugates, or DACs. These targeted cancer therapies combine properties of antibody drug conjugates and protein degraders in order to overcome limitations of both types of therapies.
Through a new partnership, up to 12 million members of Cigna’s employer customers will gain access to HelloFresh’s meals at a discounted rate. Cigna and HelloFresh are also partnering to provide free meal kits to those battling food insecurity in local communities.